INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | -23.7% | 6,528 | -1.6% | 0.00% | -20.0% |
| Q2 2023 | $270 | +13.9% | 6,633 | +4.3% | 0.01% | 0.0% |
| Q1 2023 | $237 | +20.9% | 6,360 | +13.2% | 0.01% | +25.0% |
| Q4 2022 | $196 | -100.0% | 5,620 | -35.9% | 0.00% | -71.4% |
| Q3 2022 | $490,000 | +349.5% | 8,772 | +314.6% | 0.01% | +366.7% |
| Q2 2022 | $109,000 | +12.4% | 2,116 | +57.0% | 0.00% | +50.0% |
| Q1 2022 | $97,000 | -56.9% | 1,348 | -19.8% | 0.00% | -60.0% |
| Q3 2021 | $225,000 | -10.0% | 1,680 | +8.4% | 0.01% | 0.0% |
| Q2 2021 | $250,000 | +104.9% | 1,550 | +1.3% | 0.01% | +150.0% |
| Q1 2021 | $122,000 | +64.9% | 1,530 | +12.1% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | +640.0% | 1,365 | +170.8% | 0.00% | – |
| Q3 2020 | $10,000 | – | 504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |